Stratatech | Wisconsin Investment Partners

FDA application submitted for Stratatech tissue to treat burns

Stratatech, a Madison company developing regenerative tissue as an alternative to skin grafts in treating burns, has submitted a biologics license application to the Food and Drug Administration, the company said Tuesday.

Stratatech expands facility for making skin tissue for severe burn patients

By Erik Lorenzsonn Mallinckrodt, a global pharmaceutical company, unveiled its expanded production facility for StrataTech’s lab-grown skin tissue therapy last week. Photo by ERIK LORENZSONN One of the city’s largest and oldest bioscience operations has...

Stratatech Gets $26M More to Develop Skin Tissue for Treating Burns

Jeff Buchanan October 16th, 2018 @_jeffbuchanan @xconomy Like Us Xconomy Wisconsin — An agency within the U.S. Department of Health and Human Services has awarded Stratatech, a Madison, WI-based maker of human skin tissue, $26 million in new funding. Stratatech, which...

FDA application submitted for Stratatech tissue to treat burns

Stratatech expands facility for making skin tissue for severe burn patients

Stratatech Gets $26M More to Develop Skin Tissue for Treating Burns

Recent Posts

Recent Comments

Archives

Categories

Meta